Animal Performance Enhancers Comprehensive Study by Type (Antibiotic, Hormonal, Probiotic and Prebiotic, Organic Acid, Phytogenics, Others), Animal Class (Livestock, Aquaculture, Poultry, Porcine, Equine), Animal Groups (Arthropods, Annelids, Chordates) Players and Region - Global Market Outlook to 2028

Animal Performance Enhancers Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Animal Performance Enhancers
Animal performance enhancers are defined as chemicals or drugs. These chemicals help animals for digesting their food more effectively, getting the maximum benefit out of it, and by this, the animals develop strong and healthy adults. These chemicals also protect the animal from various types of microbial diseases. Animal growth enhancers help the animals gain more fat and weight which helps in more amount of flesh production. It includes products such as feed enzymes, antibiotics, organic acids, probiotics & prebiotics, which help to enhance the growth in performance of animals.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Companies in the market are concentrating on Animal's growth and performance. In the Asia Pacific region, increasing demand for meat from various countries such as India, China, Thailand, Malaysia, Vietnam, and Indonesia. And the overall increase in population coupled with increasing disposable income drive the growth of the market. The strong presence of meat processing industries fuels the market growth in the North American region. Analyst at AMA Research estimates that United States Manufacturers will contribute the maximum growth to Global Animal Performance Enhancers market throughout the forecasted period. Established and emerging Manufacturers should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bioniche Life Sciences Inc. (Canada), Bayer Animal Health GmbH (Germany), DSM N.V. Merck & Co. Inc. (US), Biomin Holding Gmbh (German), Boehringer Ingelheim International GmbH (Germany), Cargill Inc. (US), Zoetis Inc. (US), AB Vista Inc. (UK), The Alltech Groupare (US), Elanco Animal Health Incorporated (US), Bupo Animal Health (South Africa), Chr. Hansen A/S (Denmark), Danisco A/S (Denmark) and Novus International Inc. (US) are some of the key players that are part of study coverage. Additionally, the Manufacturers which are also part of the research coverage are Merck and Co. Inc. (US), Vetoquinol (France) and Bupo Animal Health (SA).

Segmentation Overview
AMA Research has segmented the market of Global Animal Performance Enhancers market by Type (Antibiotic, Hormonal, Probiotic and Prebiotic, Organic Acid, Phytogenics and Others) and Region.



On the basis of geography, the market of Animal Performance Enhancers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Animal Class , the sub-segment i.e. Livestock will boost the Animal Performance Enhancers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Animal Groups, the sub-segment i.e. Arthropods will boost the Animal Performance Enhancers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing competition and the changing market dynamics

Market Growth Drivers:
Reduced production cost and Increase in demand for food from an animal source

Challenges:
Lack of knowledge among consumers about animal performance enhancers

Restraints:
Stringent rules and Increasing side effects and growing bacterial resistance

Opportunities:
Rising population and increasing disposable income levels and increase the protein-rich food demand

Market Leaders and their expansionary development strategies
In February 2021, Kemin Industries, a global leader in ingredient manufacturing launched KemTRACE Chromium-OR, a feed ingredient for use in cattle, swine, broiler, and horse diets. The newly launched feed ingredient is the organic-compliant source of chromium propionate that helps to improve glucose utilization and reduce the negative impacts of stress. With this launch, the main aim of the company is to expand its KemTRACE portfolio and advance product offering to improve the health & performance of animals.
October 9, 2021: Cargill Inc. launched essential oils of poultry feeds (Nutrena Naturewise) that maximize egg production, size, and production, enhanced overall wellness.
US FDA banned the use of antibiotics as feed supplements that helps livestock and poultry to grow faster. The rule includes the restriction on the OTC sale of supplements to farmers. The FDA is also working to promote immunization, clean water, and improved sanitation for farm hygiene.

Key Target Audience
REgulatory Bodies, Research Institutions, Industries, Healthcare Industries and Suppliers

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Antibiotic
  • Hormonal
  • Probiotic and Prebiotic
  • Organic Acid
  • Phytogenics
  • Others
By Animal Class
  • Livestock
  • Aquaculture
  • Poultry
  • Porcine
  • Equine

By Animal Groups
  • Arthropods
  • Annelids
  • Chordates

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Reduced production cost
      • 3.2.2. Increase in demand for food from an animal source
    • 3.3. Market Challenges
      • 3.3.1. Lack of knowledge among consumers about animal performance enhancers
    • 3.4. Market Trends
      • 3.4.1. Growing competition and the changing market dynamics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Performance Enhancers, by Type, Animal Class , Animal Groups and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Animal Performance Enhancers (Value)
      • 5.2.1. Global Animal Performance Enhancers by: Type (Value)
        • 5.2.1.1. Antibiotic
        • 5.2.1.2. Hormonal
        • 5.2.1.3. Probiotic and Prebiotic
        • 5.2.1.4. Organic Acid
        • 5.2.1.5. Phytogenics
        • 5.2.1.6. Others
      • 5.2.2. Global Animal Performance Enhancers by: Animal Groups (Value)
        • 5.2.2.1. Arthropods
        • 5.2.2.2. Annelids
        • 5.2.2.3. Chordates
      • 5.2.3. Global Animal Performance Enhancers Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Animal Performance Enhancers (Price)
      • 5.3.1. Global Animal Performance Enhancers by: Type (Price)
  • 6. Animal Performance Enhancers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bioniche Life Sciences Inc. (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer Animal Health GmbH (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. DSM N.V. Merck & Co. Inc. (US)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biomin Holding Gmbh (German)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cargill Inc. (US)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zoetis Inc. (US)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AB Vista Inc. (UK)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Alltech Groupare (US)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Elanco Animal Health Incorporated (US)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bupo Animal Health (South Africa)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Chr. Hansen A/S (Denmark)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Danisco A/S (Denmark)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Novus International Inc. (US)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Animal Performance Enhancers Sale, by Type, Animal Class , Animal Groups and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Animal Performance Enhancers (Value)
      • 7.2.1. Global Animal Performance Enhancers by: Type (Value)
        • 7.2.1.1. Antibiotic
        • 7.2.1.2. Hormonal
        • 7.2.1.3. Probiotic and Prebiotic
        • 7.2.1.4. Organic Acid
        • 7.2.1.5. Phytogenics
        • 7.2.1.6. Others
      • 7.2.2. Global Animal Performance Enhancers by: Animal Groups (Value)
        • 7.2.2.1. Arthropods
        • 7.2.2.2. Annelids
        • 7.2.2.3. Chordates
      • 7.2.3. Global Animal Performance Enhancers Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Animal Performance Enhancers (Price)
      • 7.3.1. Global Animal Performance Enhancers by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Performance Enhancers: by Type(USD Million)
  • Table 2. Animal Performance Enhancers Antibiotic , by Region USD Million (2017-2022)
  • Table 3. Animal Performance Enhancers Hormonal , by Region USD Million (2017-2022)
  • Table 4. Animal Performance Enhancers Probiotic and Prebiotic , by Region USD Million (2017-2022)
  • Table 5. Animal Performance Enhancers Organic Acid , by Region USD Million (2017-2022)
  • Table 6. Animal Performance Enhancers Phytogenics , by Region USD Million (2017-2022)
  • Table 7. Animal Performance Enhancers Others , by Region USD Million (2017-2022)
  • Table 8. Animal Performance Enhancers: by Animal Groups(USD Million)
  • Table 9. Animal Performance Enhancers Arthropods , by Region USD Million (2017-2022)
  • Table 10. Animal Performance Enhancers Annelids , by Region USD Million (2017-2022)
  • Table 11. Animal Performance Enhancers Chordates , by Region USD Million (2017-2022)
  • Table 12. South America Animal Performance Enhancers, by Country USD Million (2017-2022)
  • Table 13. South America Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 14. South America Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 15. South America Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 16. Brazil Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 17. Brazil Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 18. Brazil Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 19. Argentina Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 20. Argentina Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 21. Argentina Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 22. Rest of South America Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 23. Rest of South America Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 24. Rest of South America Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 25. Asia Pacific Animal Performance Enhancers, by Country USD Million (2017-2022)
  • Table 26. Asia Pacific Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 27. Asia Pacific Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 28. Asia Pacific Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 29. China Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 30. China Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 31. China Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 32. Japan Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 33. Japan Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 34. Japan Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 35. India Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 36. India Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 37. India Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 38. South Korea Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 39. South Korea Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 40. South Korea Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 41. Taiwan Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 42. Taiwan Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 43. Taiwan Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 44. Australia Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 45. Australia Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 46. Australia Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 50. Europe Animal Performance Enhancers, by Country USD Million (2017-2022)
  • Table 51. Europe Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 52. Europe Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 53. Europe Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 54. Germany Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 55. Germany Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 56. Germany Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 57. France Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 58. France Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 59. France Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 60. Italy Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 61. Italy Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 62. Italy Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 63. United Kingdom Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 64. United Kingdom Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 65. United Kingdom Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 66. Netherlands Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 67. Netherlands Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 68. Netherlands Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 69. Rest of Europe Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 70. Rest of Europe Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 71. Rest of Europe Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 72. MEA Animal Performance Enhancers, by Country USD Million (2017-2022)
  • Table 73. MEA Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 74. MEA Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 75. MEA Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 76. Middle East Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 77. Middle East Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 78. Middle East Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 79. Africa Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 80. Africa Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 81. Africa Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 82. North America Animal Performance Enhancers, by Country USD Million (2017-2022)
  • Table 83. North America Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 84. North America Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 85. North America Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 86. United States Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 87. United States Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 88. United States Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 89. Canada Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 90. Canada Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 91. Canada Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 92. Mexico Animal Performance Enhancers, by Type USD Million (2017-2022)
  • Table 93. Mexico Animal Performance Enhancers, by Animal Class USD Million (2017-2022)
  • Table 94. Mexico Animal Performance Enhancers, by Animal Groups USD Million (2017-2022)
  • Table 95. Animal Performance Enhancers: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Animal Performance Enhancers: by Type(USD Million)
  • Table 111. Animal Performance Enhancers Antibiotic , by Region USD Million (2023-2028)
  • Table 112. Animal Performance Enhancers Hormonal , by Region USD Million (2023-2028)
  • Table 113. Animal Performance Enhancers Probiotic and Prebiotic , by Region USD Million (2023-2028)
  • Table 114. Animal Performance Enhancers Organic Acid , by Region USD Million (2023-2028)
  • Table 115. Animal Performance Enhancers Phytogenics , by Region USD Million (2023-2028)
  • Table 116. Animal Performance Enhancers Others , by Region USD Million (2023-2028)
  • Table 117. Animal Performance Enhancers: by Animal Groups(USD Million)
  • Table 118. Animal Performance Enhancers Arthropods , by Region USD Million (2023-2028)
  • Table 119. Animal Performance Enhancers Annelids , by Region USD Million (2023-2028)
  • Table 120. Animal Performance Enhancers Chordates , by Region USD Million (2023-2028)
  • Table 121. South America Animal Performance Enhancers, by Country USD Million (2023-2028)
  • Table 122. South America Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 123. South America Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 124. South America Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 125. Brazil Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 126. Brazil Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 127. Brazil Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 128. Argentina Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 129. Argentina Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 130. Argentina Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 131. Rest of South America Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 132. Rest of South America Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 133. Rest of South America Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 134. Asia Pacific Animal Performance Enhancers, by Country USD Million (2023-2028)
  • Table 135. Asia Pacific Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 136. Asia Pacific Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 137. Asia Pacific Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 138. China Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 139. China Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 140. China Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 141. Japan Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 142. Japan Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 143. Japan Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 144. India Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 145. India Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 146. India Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 147. South Korea Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 148. South Korea Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 149. South Korea Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 150. Taiwan Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 151. Taiwan Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 152. Taiwan Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 153. Australia Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 154. Australia Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 155. Australia Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 156. Rest of Asia-Pacific Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 159. Europe Animal Performance Enhancers, by Country USD Million (2023-2028)
  • Table 160. Europe Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 161. Europe Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 162. Europe Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 163. Germany Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 164. Germany Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 165. Germany Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 166. France Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 167. France Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 168. France Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 169. Italy Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 170. Italy Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 171. Italy Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 172. United Kingdom Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 173. United Kingdom Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 174. United Kingdom Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 175. Netherlands Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 176. Netherlands Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 177. Netherlands Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 178. Rest of Europe Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 179. Rest of Europe Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 180. Rest of Europe Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 181. MEA Animal Performance Enhancers, by Country USD Million (2023-2028)
  • Table 182. MEA Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 183. MEA Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 184. MEA Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 185. Middle East Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 186. Middle East Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 187. Middle East Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 188. Africa Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 189. Africa Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 190. Africa Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 191. North America Animal Performance Enhancers, by Country USD Million (2023-2028)
  • Table 192. North America Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 193. North America Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 194. North America Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 195. United States Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 196. United States Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 197. United States Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 198. Canada Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 199. Canada Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 200. Canada Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 201. Mexico Animal Performance Enhancers, by Type USD Million (2023-2028)
  • Table 202. Mexico Animal Performance Enhancers, by Animal Class USD Million (2023-2028)
  • Table 203. Mexico Animal Performance Enhancers, by Animal Groups USD Million (2023-2028)
  • Table 204. Animal Performance Enhancers: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Performance Enhancers: by Type USD Million (2017-2022)
  • Figure 5. Global Animal Performance Enhancers: by Animal Groups USD Million (2017-2022)
  • Figure 6. South America Animal Performance Enhancers Share (%), by Country
  • Figure 7. Asia Pacific Animal Performance Enhancers Share (%), by Country
  • Figure 8. Europe Animal Performance Enhancers Share (%), by Country
  • Figure 9. MEA Animal Performance Enhancers Share (%), by Country
  • Figure 10. North America Animal Performance Enhancers Share (%), by Country
  • Figure 11. Global Animal Performance Enhancers: by Type USD/Units (2017-2022)
  • Figure 12. Global Animal Performance Enhancers share by Players 2022 (%)
  • Figure 13. Global Animal Performance Enhancers share by Players (Top 3) 2022(%)
  • Figure 14. Global Animal Performance Enhancers share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bioniche Life Sciences Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 17. Bioniche Life Sciences Inc. (Canada) Revenue: by Geography 2022
  • Figure 18. Bayer Animal Health GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Bayer Animal Health GmbH (Germany) Revenue: by Geography 2022
  • Figure 20. DSM N.V. Merck & Co. Inc. (US) Revenue, Net Income and Gross profit
  • Figure 21. DSM N.V. Merck & Co. Inc. (US) Revenue: by Geography 2022
  • Figure 22. Biomin Holding Gmbh (German) Revenue, Net Income and Gross profit
  • Figure 23. Biomin Holding Gmbh (German) Revenue: by Geography 2022
  • Figure 24. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2022
  • Figure 26. Cargill Inc. (US) Revenue, Net Income and Gross profit
  • Figure 27. Cargill Inc. (US) Revenue: by Geography 2022
  • Figure 28. Zoetis Inc. (US) Revenue, Net Income and Gross profit
  • Figure 29. Zoetis Inc. (US) Revenue: by Geography 2022
  • Figure 30. AB Vista Inc. (UK) Revenue, Net Income and Gross profit
  • Figure 31. AB Vista Inc. (UK) Revenue: by Geography 2022
  • Figure 32. The Alltech Groupare (US) Revenue, Net Income and Gross profit
  • Figure 33. The Alltech Groupare (US) Revenue: by Geography 2022
  • Figure 34. Elanco Animal Health Incorporated (US) Revenue, Net Income and Gross profit
  • Figure 35. Elanco Animal Health Incorporated (US) Revenue: by Geography 2022
  • Figure 36. Bupo Animal Health (South Africa) Revenue, Net Income and Gross profit
  • Figure 37. Bupo Animal Health (South Africa) Revenue: by Geography 2022
  • Figure 38. Chr. Hansen A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 39. Chr. Hansen A/S (Denmark) Revenue: by Geography 2022
  • Figure 40. Danisco A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 41. Danisco A/S (Denmark) Revenue: by Geography 2022
  • Figure 42. Novus International Inc. (US) Revenue, Net Income and Gross profit
  • Figure 43. Novus International Inc. (US) Revenue: by Geography 2022
  • Figure 44. Global Animal Performance Enhancers: by Type USD Million (2023-2028)
  • Figure 45. Global Animal Performance Enhancers: by Animal Groups USD Million (2023-2028)
  • Figure 46. South America Animal Performance Enhancers Share (%), by Country
  • Figure 47. Asia Pacific Animal Performance Enhancers Share (%), by Country
  • Figure 48. Europe Animal Performance Enhancers Share (%), by Country
  • Figure 49. MEA Animal Performance Enhancers Share (%), by Country
  • Figure 50. North America Animal Performance Enhancers Share (%), by Country
  • Figure 51. Global Animal Performance Enhancers: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Bioniche Life Sciences Inc. (Canada)
  • Bayer Animal Health GmbH (Germany)
  • DSM N.V. Merck & Co. Inc. (US)
  • Biomin Holding Gmbh (German)
  • Boehringer Ingelheim International GmbH (Germany)
  • Cargill Inc. (US)
  • Zoetis Inc. (US)
  • AB Vista Inc. (UK)
  • The Alltech Groupare (US)
  • Elanco Animal Health Incorporated (US)
  • Bupo Animal Health (South Africa)
  • Chr. Hansen A/S (Denmark)
  • Danisco A/S (Denmark)
  • Novus International Inc. (US)
Additional players considered in the study are as follows:
Merck and Co. Inc. (US) , Vetoquinol (France) , Bupo Animal Health (SA)
Select User Access Type

Key Highlights of Report


Jun 2023 158 Pages 70 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bioniche Life Sciences Inc. (Canada), Bayer Animal Health GmbH (Germany), DSM N.V. Merck & Co. Inc. (US), Biomin Holding Gmbh (German), Boehringer Ingelheim International GmbH (Germany), Cargill Inc. (US), Zoetis Inc. (US), AB Vista Inc. (UK), The Alltech Groupare (US), Elanco Animal Health Incorporated (US), Bupo Animal Health (South Africa), Chr. Hansen A/S (Denmark), Danisco A/S (Denmark) and Novus International Inc. (US) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing competition and the changing market dynamics" is seen as one of major influencing trends for Animal Performance Enhancers Market during projected period 2022-2028.
The Animal Performance Enhancers market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Animal Performance Enhancers Report?